15.10
Cancer survival analysis measures the time from diagnosis or start of the treatment to an event like recurrence or death.
This analysis is crucial for evaluating the effectiveness of new drugs or treatment methods and understanding survival factors.
Survival analysis helps guide clinical decisions, frame prognosis, and shape oncology research despite the challenge of incomplete data due to censoring.
Some commonly used cancer survival analysis methods include the Kaplan-Meier estimator for survival probabilities and Cox regression for risk adjustment over time.
The study types range from simple estimators to complex models considering multiple influencing factors, enhancing comparative survival evaluations.
One example of its use is in analyzing ovarian cancer patients, revealing critical early survival rates through Kaplan-Meier curves.
Another practical application of survival analysis studies involves assessing the survival benefit of radiotherapy in breast cancer. The study results indicate whether treatment plays a significant role in improving survival rates.
Kankeroverlevingsanalyse richt zich op het kwantificeren en interpreteren van de tijd vanaf een belangrijk startpunt, zoals diagnose of het begin van…
Copyright © 2026 MyJoVE Corporation. Alle rechten voorbehouden.